Loading...

Andrew T M Vaughan

Title(s)Professor, Radiation Oncology
SchoolUniversity of California, Davis
Phone916-734-8726
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Han S, Wei R, Zhang X, Jiang N, Fan M, Huang JH, Xie B, Zhang L, Miao W, Butler AC, Coleman MA, Vaughan AT, Wang Y, Chen HW, Liu J, Li JJ. CPT1A/2-Mediated FAO Enhancement-A Metabolic Target in Radioresistant Breast Cancer. Front Oncol. 2019; 9:1201. PMID: 31803610.
      View in: PubMed
    2. Rash D, Daly ME, Durbin-Johnson B, Vaughan AT, Chen AM. Treatment outcomes in HPV-negative oropharyngeal cancer: Surgery plus radiotherapy vs. definitive chemoradiotherapy. Ear Nose Throat J. 2018 Aug; 97(8):E1-E7. PMID: 30138518.
      View in: PubMed
    3. Dahal LN, Huang CY, Stopforth RJ, Mead A, Chan K, Bowater JX, Taylor MC, Narang P, Chan HTC, Kim JH, Vaughan AT, Forconi F, Beers SA. Shaving Is an Epiphenomenon of Type I and II Anti-CD20-Mediated Phagocytosis, whereas Antigenic Modulation Limits Type I Monoclonal Antibody Efficacy. J Immunol. 2018 08 15; 201(4):1211-1221. PMID: 29997125.
      View in: PubMed
    4. Pauls SD, Ray A, Hou S, Vaughan AT, Cragg MS, Marshall AJ. Fc?RIIB-Independent Mechanisms Controlling Membrane Localization of the Inhibitory Phosphatase SHIP in Human B Cells. J Immunol. 2016 09 01; 197(5):1587-96. PMID: 27456487.
      View in: PubMed
    5. Friedman DA, Tait L, Vaughan AT. Influence of nuclear structure on the formation of radiation-induced lethal lesions. Int J Radiat Biol. 2016 05; 92(5):229-40. PMID: 26917327.
      View in: PubMed
    6. Hess CB, Thompson HM, Benedict SH, Seibert JA, Wong K, Vaughan AT, Chen AM. Exposure Risks Among Children Undergoing Radiation Therapy: Considerations in the Era of Image Guided Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Apr 01; 94(5):978-92. PMID: 27026304.
      View in: PubMed
    7. Sapareto SA, Vaughan AT, Orton CG. Point/Counterpoint. Spontaneous tumors in pets are an excellent translational model for human cancers. Med Phys. 2015 Nov; 42(11):6127-9. PMID: 26520705.
      View in: PubMed
    8. Tutt AL, James S, Laversin SA, Tipton TR, Ashton-Key M, French RR, Hussain K, Vaughan AT, Dou L, Earley A, Dahal LN, Lu C, Dunscombe M, Chan HT, Penfold CA, Kim JH, Potter EA, Mockridge CI, Roghanian A, Oldham RJ, Cox KL, Lim SH, Teige I, Frendéus B, Glennie MJ, Beers SA, Cragg MS. Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fc? Receptors. J Immunol. 2015 Dec 01; 195(11):5503-16. PMID: 26512139.
      View in: PubMed
    9. Liu R, Fan M, Candas D, Qin L, Zhang X, Eldridge A, Zou JX, Zhang T, Juma S, Jin C, Li RF, Perks J, Sun LQ, Vaughan AT, Hai CX, Gius DR, Li JJ. CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance. Mol Cancer Ther. 2015 Sep; 14(9):2090-102. PMID: 26141949.
      View in: PubMed
    10. Cui Y, Qin L, Wu J, Qu X, Hou C, Sun W, Li S, Vaughan AT, Li JJ, Liu J. SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells. PLoS One. 2015; 10(6):e0129834. PMID: 26121691.
      View in: PubMed
    11. Jin C, Qin L, Shi Y, Candas D, Fan M, Lu CL, Vaughan AT, Shen R, Wu LS, Liu R, Li RF, Murley JS, Woloschak G, Grdina DJ, Li JJ. CDK4-mediated MnSOD activation and mitochondrial homeostasis in radioadaptive protection. Free Radic Biol Med. 2015 Apr; 81:77-87. PMID: 25578653.
      View in: PubMed
    12. Wright RL, Slemmons KK, Vaughan AT. Estradiol induces gene proximity and MLL-MLLT3 fusion in an activation-induced cytidine deaminase-mediated pathway. Leuk Lymphoma. 2015 May; 56(5):1460-5. PMID: 25130479.
      View in: PubMed
    13. Wright RL, Vaughan AT. A systematic description of MLL fusion gene formation. Crit Rev Oncol Hematol. 2014 Sep; 91(3):283-91. PMID: 24787275.
      View in: PubMed
    14. Hess CB, Rash DL, Daly ME, Farwell DG, Bishop J, Vaughan AT, Wilson MD, Chen AM. Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy. JAMA Otolaryngol Head Neck Surg. 2014 Apr; 140(4):312-6. PMID: 24526276.
      View in: PubMed
    15. Singh S, Shih SJ, Vaughan AT. Detection of DNA double-strand breaks and chromosome translocations using ligation-mediated PCR and inverse PCR. Methods Mol Biol. 2014; 1105:399-415. PMID: 24623244.
      View in: PubMed
    16. Chen AM, Zahra T, Daly ME, Farwell DG, Luu Q, Gandour-Edwards R, Vaughan AT. Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer. Head Neck. 2013 Nov; 35(11):1652-6. PMID: 23335285.
      View in: PubMed
    17. Do TU, Ho B, Shih SJ, Vaughan A. Zinc Finger Nuclease induced DNA double stranded breaks and rearrangements in MLL. Mutat Res. 2012 Dec; 740(1-2):34-42. PMID: 23291497.
      View in: PubMed
    18. Candas D, Fan M, Nantajit D, Vaughan AT, Murley JS, Woloschak GE, Grdina DJ, Li JJ. CyclinB1/Cdk1 phosphorylates mitochondrial antioxidant MnSOD in cell adaptive response to radiation stress. J Mol Cell Biol. 2013 Jun; 5(3):166-75. PMID: 23243068.
      View in: PubMed
    19. Chen AM, Li J, Beckett LA, Zhara T, Farwell G, Lau DH, Gandour-Edwards R, Vaughan AT, Purdy JA. Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer. Laryngoscope. 2013 Jan; 123(1):152-7. PMID: 23008061.
      View in: PubMed
    20. Shih SJ, Fass J, Buffalo V, Lin D, Singh SP, Diaz MO, Vaughan AT. Multiple clonal MLL fusions in a patient receiving CHOP-based chemotherapy. Br J Haematol. 2012 Oct; 159(1):50-7. PMID: 22845170.
      View in: PubMed
    21. Ho B, Baker PM, Singh S, Shih SJ, Vaughan AT. Localized DNA cleavage secondary to genotoxic exposure adjacent to an Alu inverted repeat. Genes Chromosomes Cancer. 2012 May; 51(5):501-9. PMID: 22334386.
      View in: PubMed
    22. Chen AM, Chen LM, Vaughan A, Farwell DG, Luu Q, Purdy JA, Vijayakumar S. Head and neck cancer among lifelong never-smokers and ever-smokers: matched-pair analysis of outcomes after radiation therapy. Am J Clin Oncol. 2011 Jun; 34(3):270-5. PMID: 20622648.
      View in: PubMed
    23. Mooso B, Madhav A, Johnson S, Roy M, Moore ME, Moy C, Loredo GA, Mehta RG, Vaughan AT, Ghosh PM. Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1a-Hydroxyvitamin D5 - a calcitriol analog. Genes Cancer. 2010 Nov 16; 1(9):927-940. PMID: 21552398.
      View in: PubMed
    24. Du N, Baker PM, Do TU, Bien C, Bier-Laning CM, Singh S, Shih SJ, Diaz MO, Vaughan AT. 11q21.1-11q23.3 Is a site of intrinsic genomic instability triggered by irradiation. Genes Chromosomes Cancer. 2010 Sep; 49(9):831-43. PMID: 20607707.
      View in: PubMed
    25. Vaughan AT, Brackenbury LS, Massari P, Davenport V, Gorringe A, Heyderman RS, Williams NA. Neisseria lactamica selectively induces mitogenic proliferation of the naive B cell pool via cell surface Ig. J Immunol. 2010 Sep 15; 185(6):3652-60. PMID: 20709949.
      View in: PubMed
    26. Chen AM, Chen LM, Vaughan A, Sreeraman R, Farwell DG, Luu Q, Lau DH, Stuart K, Purdy JA, Vijayakumar S. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):414-9. PMID: 20399030.
      View in: PubMed
    27. Klein EA, Guiou M, Farwell DG, Luu Q, Lau DH, Stuart K, Vaughan A, Vijayakumar S, Chen AM. Primary radiation therapy for head-and-neck cancer in the setting of human immunodeficiency virus. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):60-4. PMID: 20385454.
      View in: PubMed
    28. Singh S, Le H, Shih SJ, Ho B, Vaughan AT. Suberoylanilide hydroxyamic acid modification of chromatin architecture affects DNA break formation and repair. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):566-73. PMID: 20117292.
      View in: PubMed
    29. Le H, Singh S, Shih SJ, Du N, Schnyder S, Loredo GA, Bien C, Michaelis L, Toor A, Diaz MO, Vaughan AT. Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding. Genes Chromosomes Cancer. 2009 Sep; 48(9):806-15. PMID: 19530238.
      View in: PubMed
    30. Schnyder S, Du NT, Le HB, Singh S, Loredo GA, Vaughan AT. Estrogen treatment induces MLL aberrations in human lymphoblastoid cells. Leuk Res. 2009 Oct; 33(10):1400-4. PMID: 19264358.
      View in: PubMed
    31. Vaughan AT, Gorringe A, Davenport V, Williams NA, Heyderman RS. Absence of mucosal immunity in the human upper respiratory tract to the commensal bacteria Neisseria lactamica but not pathogenic Neisseria meningitidis during the peak age of nasopharyngeal carriage. J Immunol. 2009 Feb 15; 182(4):2231-40. PMID: 19201877.
      View in: PubMed
    32. Chen AM, Vaughan A, Narayan S, Vijayakumar S. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme. Head Neck. 2008 Dec; 30(12):1586-91. PMID: 18798313.
      View in: PubMed
    33. Yang C, Betti C, Singh S, Toor A, Vaughan A. Impaired NHEJ function in multiple myeloma. Mutat Res. 2009 Jan 15; 660(1-2):66-73. PMID: 19028508.
      View in: PubMed
    34. Straume T, Amundson SA, Blakely WF, Burns FJ, Chen A, Dainiak N, Franklin S, Leary JA, Loftus DJ, Morgan WF, Pellmar TC, Stolc V, Turteltaub KW, Vaughan AT, Vijayakumar S, Wyrobek AJ. NASA Radiation Biomarker Workshop, September 27-28, 2007. Radiat Res. 2008 Sep; 170(3):393-405. PMID: 18763867.
      View in: PubMed
    35. Narayan S, Lehmann J, Coleman MA, Vaughan A, Yang CC, Enepekides D, Farwell G, Purdy JA, Laredo G, Nolan K, Pearson FS, Vijayakumar S. Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Nov 01; 72(3):756-62. PMID: 18417299.
      View in: PubMed
    36. Guzman ML, Rossi RM, Neelakantan S, Li X, Corbett CA, Hassane DC, Becker MW, Bennett JM, Sullivan E, Lachowicz JL, Vaughan A, Sweeney CJ, Matthews W, Carroll M, Liesveld JL, Crooks PA, Jordan CT. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood. 2007 Dec 15; 110(13):4427-35. PMID: 17804695.
      View in: PubMed
    37. Xin H, D'Souza S, Jørgensen TN, Vaughan AT, Lengyel P, Kotzin BL, Choubey D. Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis. J Immunol. 2006 May 15; 176(10):5863-70. PMID: 16670293.
      View in: PubMed
    38. Villalobos MJ, Betti CJ, Vaughan AT. Detection of DNA double-strand breaks and chromosome translocations using ligation-mediated PCR and inverse PCR. Methods Mol Biol. 2006; 314:109-21. PMID: 16673878.
      View in: PubMed
    39. Betti CJ, Villalobos MJ, Jiang Q, Cline E, Diaz MO, Loredo G, Vaughan AT. Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity. Leukemia. 2005 Dec; 19(12):2289-95. PMID: 16193084.
      View in: PubMed
    40. Vaughan AT, Betti CJ, Villalobos MJ, Premkumar K, Cline E, Jiang Q, Diaz MO. Surviving apoptosis: a possible mechanism of benzene-induced leukemia. Chem Biol Interact. 2005 May 30; 153-154:179-85. PMID: 15935815.
      View in: PubMed
    41. Villalobos MJ, Betti CJ, Vaughan AT. Detection of DNA double-strand breaks and chromosome translocations using ligation-mediated PCR and inverse PCR. Methods Mol Biol. 2005; 291:279-89. PMID: 15502230.
      View in: PubMed
    42. Betti CJ, Villalobos MJ, Diaz MO, Vaughan AT. Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division. Cancer Res. 2003 Mar 15; 63(6):1377-81. PMID: 12649202.
      View in: PubMed
    43. Vaughan AT, Betti CJ, Villalobos MJ. Surviving apoptosis. Apoptosis. 2002 Apr; 7(2):173-7. PMID: 11865202.
      View in: PubMed
    44. Kamradt MC, Walter S, Koudelik J, Shafer L, Weijzen S, Velders M, Vaughan AT. Steroid-mediated inhibition of radiation-induced apoptosis in C4-1 cervical carcinoma cells is p53-dependent. Eur J Cancer. 2001 Nov; 37(17):2240-6. PMID: 11677114.
      View in: PubMed
    45. Betti CJ, Villalobos MJ, Diaz MO, Vaughan AT. Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system. Cancer Res. 2001 Jun 01; 61(11):4550-5. PMID: 11389089.
      View in: PubMed
    46. Khodarev NN, Bennett T, Shearing N, Sokolova I, Koudelik J, Walter S, Villalobos M, Vaughan AT. LINE L1 retrotransposable element is targeted during the initial stages of apoptotic DNA fragmentation. J Cell Biochem. 2000 Sep 07; 79(3):486-95. PMID: 10972985.
      View in: PubMed
    47. Kamradt MC, Mohideen N, Krueger E, Walter S, Vaughan AT. Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7. Br J Cancer. 2000 May; 82(10):1709-16. PMID: 10817508.
      View in: PubMed
    48. Kamradt MC, Mohideen N, Vaughan AT. RU486 increases radiosensitivity and restores apoptosis through modulation of HPV E6/E7 in dexamethasone-treated cervical carcinoma cells. Gynecol Oncol. 2000 Apr; 77(1):177-82. PMID: 10739708.
      View in: PubMed
    49. Narayana A, Vaughan AT, Kathuria S, Fisher SG, Walter SA, Reddy SP. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 2000 Jan 01; 46(1):21-6. PMID: 10656367.
      View in: PubMed
    50. Khodarev NN, Sokolova IA, Vaughan AT. Abortive apoptosis as an initiator of chromosomal translocations. Med Hypotheses. 1999 May; 52(5):373-6. PMID: 10416942.
      View in: PubMed
    51. Vaughan AT, Walter S, Milner AE. Measurement of low-frequency DNA breaks using nucleoid flow cytometry. Methods Mol Biol. 1999; 113:519-26. PMID: 10443447.
      View in: PubMed
    52. Sokolova IA, Vaughan AT, Khodarev NN. Mycoplasma infection can sensitize host cells to apoptosis through contribution of apoptotic-like endonuclease(s). Immunol Cell Biol. 1998 Dec; 76(6):526-34. PMID: 9893030.
      View in: PubMed
    53. Narayana A, Vaughan AT, Fisher SG, Reddy SP. Second primary tumors in laryngeal cancer: results of long-term follow-up. Int J Radiat Oncol Biol Phys. 1998 Oct 01; 42(3):557-62. PMID: 9806515.
      View in: PubMed
    54. Khodarev NN, Sokolova IA, Vaughan AT. Association between DNA cleavage during apoptosis and regions of chromatin replication. J Cell Biochem. 1998 Sep 15; 70(4):604-15. PMID: 9712157.
      View in: PubMed
    55. Narayana A, Khodarev N, Walter S, Vaughan AT. Synchronous block in DNA synthesis initiation with change in chromatin topology mediated by VP16. DNA Cell Biol. 1998 Jul; 17(7):613-9. PMID: 9703020.
      View in: PubMed
    56. Geng L, Walter S, Melian E, Vaughan AT. Transfection of a vector expressing wild-type p53 into cells of two human glioma cell lines enhances radiation toxicity. Radiat Res. 1998 Jul; 150(1):31-7. PMID: 9650599.
      View in: PubMed
    57. Khodarev NN, Sokolova IA, Vaughan AT. Mechanisms of induction of apoptotic DNA fragmentation. Int J Radiat Biol. 1998 May; 73(5):455-67. PMID: 9652802.
      View in: PubMed
    58. Krueger E, Sokolova I, Kamradt M, Khodarev NN, Vaughan AT. Multiple forms of endonuclease activity linked with radiation induced apoptosis in C4-1 cervical carcinoma cells. Anticancer Res. 1998 Mar-Apr; 18(2A):983-8. PMID: 9615751.
      View in: PubMed
    59. Narayana A, Vaughan AT, Gunaratne S, Kathuria S, Walter SA, Reddy SP. Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer. 1998 Jan 15; 82(2):286-91. PMID: 9445184.
      View in: PubMed
    60. Milner AE, Grand RJ, Vaughan AT, Armitage RJ, Gregory CD. Differential effects of BCL-2 on survival and proliferation of human B-lymphoma cells following gamma-irradiation. Oncogene. 1997 Oct 09; 15(15):1815-22. PMID: 9362448.
      View in: PubMed
    61. Khodarev NN, Narayana A, Constantinou A, Vaughan AT. Topologically constrained domains of supercoiled DNA in eukaryotic cells. DNA Cell Biol. 1997 Sep; 16(9):1051-8. PMID: 9324307.
      View in: PubMed
    62. Street D, Kaufmann AM, Vaughan A, Fisher SG, Hunter M, Schreckenberger C, Potkul RK, Gissmann L, Qiao L. Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells. Gynecol Oncol. 1997 May; 65(2):265-72. PMID: 9159336.
      View in: PubMed
    63. Constantinou AI, Mehta RG, Vaughan A. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res. 1996 Nov-Dec; 16(6A):3293-8. PMID: 9042303.
      View in: PubMed
    64. Constantinou AI, Vaughan AT, Yamasaki H, Kamath N. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation. Cancer Res. 1996 Sep 15; 56(18):4192-9. PMID: 8797591.
      View in: PubMed
    65. Erlich E, McCall AR, Potkul RK, Walter S, Vaughan A. Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines. Gynecol Oncol. 1996 Feb; 60(2):251-4. PMID: 8631547.
      View in: PubMed
    66. Wakim BT, Grutkoski PS, Vaughan AT, Engelmann GL. Stimulation of a Ca(2+)-calmodulin-activated histone 3 arginine kinase in quiescent rat heart endothelial cells compared to actively dividing cells. J Biol Chem. 1995 Sep 29; 270(39):23155-8. PMID: 7559461.
      View in: PubMed
    67. Zhen W, Denault CM, Loviscek K, Walter S, Geng L, Vaughan AT. The relative radiosensitivity of TK6 and WI-L2-NS lymphoblastoid cells derived from a common source is primarily determined by their p53 mutational status. Mutat Res. 1995 Feb; 346(2):85-92. PMID: 7885404.
      View in: PubMed
    68. Constantinou A, Mehta R, Runyan C, Rao K, Vaughan A, Moon R. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J Nat Prod. 1995 Feb; 58(2):217-25. PMID: 7769390.
      View in: PubMed
    69. Zhen W, Vaughan AT. Effect of caffeine on radiation-induced apoptosis in TK6 cells. Radiat Res. 1995 Feb; 141(2):170-5. PMID: 7838955.
      View in: PubMed
    70. Vaughan AT, Anderson P, Wallace DM, Beaney RP, Lynch TH. Local control of T2/3 transitional cell carcinoma of bladder is correlated to differences in DNA supercoiling: evidence for two discrete tumor populations. Cancer Res. 1993 May 15; 53(10 Suppl):2300-3. PMID: 8485715.
      View in: PubMed
    71. Schwartz JL, Cowen JM, Moan E, Sedita BA, Stephens J, Vaughan AT. Metaphase chromosome and nucleoid differences between CHO-K1 and its radiosensitive derivative xrs-5. Mutagenesis. 1993 Mar; 8(2):105-8. PMID: 8464379.
      View in: PubMed
    72. Schwartz JL, Vaughan AT. DNA-nuclear matrix interactions and ionizing radiation sensitivity. Environ Mol Mutagen. 1993; 22(4):231-3. PMID: 8223503.
      View in: PubMed
    73. Milner AE, Gordon DJ, Turner BM, Vaughan AT. A correlation between DNA-nuclear matrix binding and relative radiosensitivity in two human squamous cell carcinoma cell lines. Int J Radiat Biol. 1993 Jan; 63(1):13-20. PMID: 8093463.
      View in: PubMed
    74. Vaughan AT, Gordon DJ. Hydrogen peroxide lethality is associated with a decreased ability to maintain positive DNA supercoiling. Exp Cell Res. 1992 Oct; 202(2):376-80. PMID: 1397090.
      View in: PubMed
    75. Lynch TH, Anderson P, Wallace DM, Kondratowicz GM, Beaney RP, Vaughan AT. A correlation between nuclear supercoiling and the response of patients with bladder cancer to radiotherapy. Br J Cancer. 1991 Nov; 64(5):867-71. PMID: 1931607.
      View in: PubMed
    76. Vaughan AT, Milner AM, Gordon DG, Schwartz JL. Interaction between ionizing radiation and supercoiled DNA within human tumor cells. Cancer Res. 1991 Aug 01; 51(15):3857-61. PMID: 1855203.
      View in: PubMed
    77. Vaughan AT, Gordon DJ, Chettle DR, Green S. Neutron and cobalt-60 gamma irradiation produce similar changes in DNA supercoiling. Radiat Res. 1991 Jul; 127(1):19-23. PMID: 2068267.
      View in: PubMed
    78. Meechan PJ, Vaughan AT, Giometti CS, Grdina DJ. Association of WR-1065 with CHO AA8 cells, nuclei, and nucleoids. Radiat Res. 1991 Feb; 125(2):152-7. PMID: 1996372.
      View in: PubMed
    79. Vaughan AT, Allan IM, Gordon DJ, Grdina DJ, Milner AM. Analysis of free radical damage within single cells using flow cytometry. Mol Aspects Med. 1991; 12(2):129-35. PMID: 1712885.
      View in: PubMed
    80. Gordon DJ, Milner AE, Beaney RP, Grdina DJ, Vaughan AT. Cellular radiosensitivity in V79 cells is linked to alterations in chromatin structure. Int J Radiat Oncol Biol Phys. 1990 Nov; 19(5):1199-201. PMID: 2254112.
      View in: PubMed
    81. Gordon DJ, Milner AE, Beaney RP, Grdina DJ, Vaughan AT. The increase in radioresistance of Chinese hamster cells cultured as spheroids is correlated to changes in nuclear morphology. Radiat Res. 1990 Feb; 121(2):175-9. PMID: 2305035.
      View in: PubMed
    82. Wallis TS, Vaughan AT, Clarke GJ, Qi GM, Worton KJ, Candy DC, Osborne MP, Stephen J. The role of leucocytes in the induction of fluid secretion by Salmonella typhimurium. J Med Microbiol. 1990 Jan; 31(1):27-35. PMID: 2404124.
      View in: PubMed
    83. Schwartz JL, Shadley JD, Jaffe DR, Whitlock J, Rotmensch J, Cowan JM, Gordon DJ, Vaughan AT. Association between radiation sensitivity, DNA repair and chromosome organization in the Chinese hamster ovary cell line xrs-5. Prog Clin Biol Res. 1990; 340A:255-64. PMID: 2388914.
      View in: PubMed
    84. Vaughan AT, Grdina DJ, Meechan PJ, Milner AE, Gordon DJ. Conformational changes in chromatin structure induced by the radioprotective aminothiol, WR 1065. Br J Cancer. 1989 Dec; 60(6):893-6. PMID: 2605099.
      View in: PubMed
    85. Schwartz JL, Vaughan AT. Association among DNA/chromosome break rejoining rates, chromatin structure alterations, and radiation sensitivity in human tumor cell lines. Cancer Res. 1989 Sep 15; 49(18):5054-7. PMID: 2766277.
      View in: PubMed
    86. Keeling AA, Vaughan AT, Beaney RP. Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias. Br J Cancer. 1989 Jul; 60(1):74-8. PMID: 2803919.
      View in: PubMed
    87. Gordon DJ, Milner AE, Vaughan AT, Chipman JK. The use of flow cytometry in the detection of radiation- and chemically induced nuclear damage in human mononuclear cells. Mutagenesis. 1989 Jan; 4(1):35-8. PMID: 2469939.
      View in: PubMed
    88. Allan IM, Vaughan AT, Milner AE, Lunec J, Bacon PA. Structural damage to lymphocyte nuclei by H2O2 or gamma irradiation is dependent on the mechanism of OH. radical production. Br J Cancer. 1988 Jul; 58(1):34-7. PMID: 3166891.
      View in: PubMed
    89. Anderson P, Vaughan AT, Varley NR. Antibodies labeled with 199Au: potential of 199Au for radioimmunotherapy. Int J Rad Appl Instrum B. 1988; 15(3):293-7. PMID: 3384677.
      View in: PubMed
    90. Vaughan AT, Anderson P, Dykes PW, Chapman CE, Bradwell AR. Limitations to the killing of tumours using radiolabelled antibodies. Br J Radiol. 1987 Jun; 60(714):567-72. PMID: 3620814.
      View in: PubMed
    91. Dykes PW, Bradwell AR, Chapman CE, Vaughan AT. Radioimmunotherapy of cancer: clinical studies and limiting factors. Cancer Treat Rev. 1987 Jun; 14(2):87-106. PMID: 3315201.
      View in: PubMed
    92. Milner AE, Vaughan AT, Clark IP. Measurement of DNA damage in mammalian cells using flow cytometry. Radiat Res. 1987 Apr; 110(1):108-17. PMID: 3562788.
      View in: PubMed
    93. Vaughan AT, Yankuba SC, Anderson P. Antibodies labeled with metallic radionuclides: influence of nuclide chemistry on dose distribution. NCI Monogr. 1987; (3):141-4. PMID: 3029601.
      View in: PubMed
    94. Bradwell AR, Vaughan AT, Dykes PW. Limitations in localising and killing tumours using radiolabelled antibodies. Nuklearmedizin. 1986 Dec; 25(6):245-8. PMID: 3808966.
      View in: PubMed
    95. Vaughan A, Chapman C, Dykes PW, Anderson P, Bradwell AR. Antibody-targeted therapy of cancer. Lancet. 1986 Oct 11; 2(8511):860. PMID: 2876299.
      View in: PubMed
    96. Vaughan AT, Bradwell AR, Dykes PW, Anderson P. Illusions of tumour killing using radiolabelled antibodies. Lancet. 1986 Jun 28; 1(8496):1492-3. PMID: 2873294.
      View in: PubMed
    97. Vaughan AT, Keeling A, Yankuba SC. The production and biological distribution of yttrium-90 labelled antibodies. Int J Appl Radiat Isot. 1985 Oct; 36(10):803-6. PMID: 4055089.
      View in: PubMed
    98. Fairweather DS, Bradwell AR, Dykes PW, Vaughan AT, Watson-James SF, Chandler S. Improved tumour localisation using indium-111 labelled antibodies. Br Med J (Clin Res Ed). 1983 Jul 16; 287(6386):167-70. PMID: 6409238.
      View in: PubMed
    99. Burnett D, Crocker J, Vaughan AT. Synthesis of cathepsin B by cells derived from the HL60 promyelocytic leukaemia cell line. J Cell Physiol. 1983 Jun; 115(3):249-54. PMID: 6343405.
      View in: PubMed
    100. Bradwell AR, Vaughan A, Fairweather DS, Dykes PW. Improved radioimmunodetection of tumours using second antibody. Lancet. 1983 Jan 29; 1(8318):247. PMID: 6130282.
      View in: PubMed
    101. Bateman WJ, Vaughan AT, Brown G. Tumour localisation of 211At-labelled monoclonal antibody to a sub-cutaneous human heterograft in the nude mouse II. Int J Nucl Med Biol. 1983; 10(4):241-4. PMID: 6582053.
      View in: PubMed
    102. Vaughan AT, Bateman WJ, Fisher DR. The in vivo fate of a 211At labelled monoclonal antibody with known specificity in a murine system. Int J Radiat Oncol Biol Phys. 1982 Nov; 8(11):1943-6. PMID: 6295988.
      View in: PubMed
    103. Vaughan AT, Bateman WJ, Brown G, Cowan J. The specific inhibition of cellular clonogenic proliferation using 211At labelled lectins and antibodies--I. Int J Nucl Med Biol. 1982; 9(3):167-71. PMID: 6957405.
      View in: PubMed
    104. Emmanuel FX, Vaughan AT, Catty D. Mice treated with strontium 90: an animal model deficient in NK cells. Br J Cancer. 1981 Aug; 44(2):160-5. PMID: 7272185.
      View in: PubMed
    105. Vaughan AT, Fremlin JH. The preparation of astatine labelled proteins using an electrophilic reaction. Int J Nucl Med Biol. 1978; 5(6):229-30. PMID: 104931.
      View in: PubMed